BCDA
BioCardia, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.17
+5.41%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.15
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.13
- EPS estimate
- -$0.18
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +19.6%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.18 | -$0.13 | Beat 27.78% | — |
| May 15, 2026 | -$0.17 | -$0.21 | Miss -23.53% | — |
| Mar 24, 2026 | -$0.20 | -$0.06 | Beat 70.00% | — |
| Nov 12, 2025 | -$0.25 | -$0.24 | Beat 4.00% | — |
| May 14, 2025 | -$0.39 | -$0.59 | Miss -51.28% | — |
| Mar 26, 2025 | -$0.87 | -$0.25 | Beat 71.26% | $25.0K |
| Nov 13, 2024 | -$1.19 | -$0.61 | Beat 48.74% | $58.0K |
| Aug 13, 2024 | -$0.10 | -$0.88 | Miss -780.00% | $3.0K |
| Nov 9, 2022 | -$3.45 | -$2.55 | Beat 26.09% | $212.0K |
| Aug 10, 2022 | -$4.20 | -$2.10 | Beat 50.00% | $974.0K |
| Nov 10, 2021 | -$0.21 | -$2.40 | Miss -1042.86% | $821.0K |
| Aug 12, 2021 | -$3.15 | -$3.00 | Beat 4.76% | $69.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026